Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
2 Predictions for Pfizer in 2026
04:30pm, Friday, 02'nd Jan 2026
Pfizer's oncology ambitions could start to take shape next year. The drugmaker is also likely to make progress in the weight-loss market.
Pfizer 2026: The Reset Year
02:52pm, Friday, 02'nd Jan 2026
Pfizer Inc. enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution, despite an aggressive strategic repositioning. The $10 billion Metsera acquisition immedi
Should You Buy Pfizer While It's Under $30?
12:37pm, Thursday, 01'st Jan 2026
Pfizer has been struggling for several years. The company's pipeline could help it turn things around.
First Look: 2026 Outlook, Buffett Exit, Fed Split, Dollar Slide
07:37am, Thursday, 01'st Jan 2026
Stock News Street sets 2026 expectations: Wall Street sees the S&P 500 posting modest-to-mid-teens gains in 2026 after a 16.39% rise in 2025, with AI leaders li
Cantor Fitzgerald Investment Advisors L.P. Has $13.94 Million Stake in Pfizer Inc. $PFE
05:24am, Thursday, 01'st Jan 2026
Cantor Fitzgerald Investment Advisors L.P. increased its stake in shares of Pfizer Inc. (NYSE: PFE) by 4.8% during the third quarter, according to its most recent Form 13F filing with the Securities a
Investing $122,100 in These 3 High-Yield Dividend Stocks Could Make You $10,000 in Reliable Passive Income in 2026
04:44am, Thursday, 01'st Jan 2026
Ares Capital offers an especially juicy dividend. Energy Transfer has an impressive track record of increasing its distribution each quarter.
Where Will Pfizer Be in 5 Years?
05:30pm, Wednesday, 31'st Dec 2025
Pfizer's stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live with the coronavirus, and Pfizer's stock has plunged as a result.
Pfizer and GSK Lead 2026 U.S. Drug Price Hikes
11:03am, Wednesday, 31'st Dec 2025
Pfizer (PFE) and GlaxoSmithKline (GSK) are among the top drugmakers planning price increases for hundreds of branded medicines in the U.S. next year, according
Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake
10:28am, Wednesday, 31'st Dec 2025
The market of 2025 will be remembered for its extremes. While investors poured billions into technology sector giants and companies manufacturing weight-loss drugs, traditional pharmaceutical leaders
Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs
09:34am, Wednesday, 31'st Dec 2025
Pfizer (PFE, Financials) and GSK (GSK, Financials) are leading a new round of price adjustments set to take effect in early 2026, with data from healthcare anal
3 ultra-high-yield stocks to consider for $300 of dividend income in 2026
08:37am, Wednesday, 31'st Dec 2025
Generating meaningful dividend income from modest capital requires disciplined stock selection and a clear mathematical framework. An allocation of $2,670 distributed equally across three carefully ve
2 Unstoppable Dividend Stocks to Double Up on Right Now
07:43am, Wednesday, 31'st Dec 2025
Both companies have faced some headwinds recently, but the core businesses and dividend payouts remain strong. Blackstone is the top alternative asset manager in the world and operates as a premier gl
Want $300 in Super-Safe Dividend Income in 2026? Invest $2,670 Into the Following 3 Ultra-High-Yield Stocks.
03:51am, Tuesday, 30'th Dec 2025
Over the last half-century, dividend stocks have notably outperformed non-payers -- and have done so while being less volatile than the benchmark S&P 500. While some ultra-high-yielding income stocks
Jim Cramer Names His Favorite Dividend Stocks
12:35pm, Monday, 29'th Dec 2025
Jim Cramer has built a strong reputation in the industry. He's the Mad Money host who carefully picks growth stocks that have the potential to survive market ups and downs.
Perigon Wealth Management LLC Has $3.83 Million Stake in Pfizer Inc. $PFE
06:13am, Monday, 29'th Dec 2025
Perigon Wealth Management LLC raised its position in Pfizer Inc. (NYSE: PFE) by 22.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Excha
